Nutritional ketosis improves exercise metabolism in patients with very long‐chain acyl‐CoA dehydrogenase deficiency
Open Access
- 18 January 2020
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 43 (4) , 787-799
Abstract
A maladaptive shift from fat to carbohydrate (CHO) oxidation during exercise is thought to underlie myopathy and exercise‐induced rhabdomyolysis in patients with fatty acid oxidation (FAO) disorders. We hypothesised that ingestion of a ketone ester (KE) drink prior to exercise could serve as an alternative oxidative substrate supply to boost muscular ATP homeostasis. To establish a rational basis for therapeutic use of KE supplementation in FAO, we tested this hypothesis in patients deficient in Very Long‐Chain acyl‐CoA Dehydrogenase (VLCAD). Five patients (range 17‐45 y; 4 M/1F) patients were included in an investigator‐initiated, randomised, blinded, placebo‐controlled, 2‐way cross‐over study. Patients drank either a KE + CHO mix or an isocaloric CHO equivalent and performed 35 minutes upright cycling followed by 10 minutes supine cycling inside a Magnetic Resonance scanner at individual maximal FAO work rate (fatmax; approximately 40% VO2max). The protocol was repeated after a 1‐week interval with the alternate drink. Primary outcome measures were quadriceps phosphocreatine (PCr), Pi and pH dynamics during exercise and recovery assayed by in vivo 31P‐MR spectroscopy. Secondary outcomes included plasma and muscle metabolites and respiratory gas exchange recordings. Ingestion of KE rapidly induced mild ketosis and increased muscle BHB content. During exercise at FATMAX, VLCADD‐specific plasma acylcarnitine levels, quadriceps glycolytic intermediate levels and in vivo Pi/PCr ratio were all lower in KE + CHO than CHO. These results provide a rational basis for future clinical trials of synthetic ketone ester supplementation therapy in patients with FAO disorders.Trial registration: ClinicalTrials.gov. Protocol ID: NCT03531554; METC2014.492; ABR51222.042.14.Keywords
Funding Information
- National Institutes of Health (072011)
- Stichting Spieren voor Spieren
This publication has 47 references indexed in Scilit:
- Clinical and biological features at diagnosis in mitochondrial fatty acid beta‐oxidation defects: a French pediatric study of 187 patientsJournal of Inherited Metabolic Disease, 2012
- Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD−/−) Mouse to Compensate a Defective Fatty Acid β-OxidationPLOS ONE, 2012
- Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjectsRegulatory Toxicology and Pharmacology, 2012
- The Cycling of Acetyl-Coenzyme A Through Acetylcarnitine Buffers Cardiac Substrate SupplyCirculation: Cardiovascular Imaging, 2012
- Mitochondrial fatty acid oxidation disorders: clinical presentation of long‐chain fatty acid oxidation defects before and after newborn screeningJournal of Inherited Metabolic Disease, 2010
- Management and outcome in 75 individuals with long‐chain fatty acid oxidation defects: results from a workshopJournal of Inherited Metabolic Disease, 2009
- Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshopJournal of Inherited Metabolic Disease, 2009
- A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyMolecular Genetics and Metabolism, 2009
- Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencyMolecular Genetics and Metabolism, 2006
- Blood lactate threshold and type II fibre predominance in patients with exertional heatstroke.Journal of Neurology, Neurosurgery & Psychiatry, 1997